Print Friendly, PDF & Email

City officials today filed a federal lawsuit against a pharmaceutical company they say cornered the market of a specialty drug and then jacked up the prices, forcing the city to pay exorbitant amounts to treat babies suffering from a rare seizure disorder.

The drug wound up costing taxpayers an estimated $500,000 to treat two infants. Rockford is suing to recover those “inflated drug payments,” asking a judge to force the pharmaceutical to set a “fair and reasonable price” for the drug and to provide compensation for Rockford and other insurers.

Read Article